...
首页> 外文期刊>Basic & clinical pharmacology & toxicology. >N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome.
【24h】

N-acetylcysteine effects on genotoxic and oxidative stress parameters in cirrhotic rats with hepatopulmonary syndrome.

机译:N-乙酰半胱氨酸对肝硬化肝肺综合征大鼠遗传毒性和氧化应激参数的影响。

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this study was to evaluate the potential antioxidant effects of N-acetylcysteine in hepatopulmonary syndrome, a complication of cirrhosis, using an experimental model of common bile duct ligation in rats. Male Wistar rats were divided into four experimental groups: CBDL (animals submitted to common bile duct ligation); Sham (animals submitted to simulated common bile duct ligation); Sham + N-acetylcysteine, and CBDL + N-acetylcysteine. N-acetylcysteine (10 mg/kg, intraperitoneally) was administered for 2 weeks starting on day 14 after surgery. Some alterations in the liver integrity were investigated by evaluation of serum enzymes aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, and arterial blood gases. Lipoperoxidation by thiobarbituric acid-reactive substances assay, superoxide dismutase activity and total nitrates was measured as parameters of oxidative stress, performed on lung homogenates. Micronucleus assay in bone marrow and comet assay in lung, liver and blood were performed to assess the genotoxic effects by oxidative stress. The results showed an improvement in the enzymatic parameters and arterial blood gases, a reduction of lipoperoxidation and in the total nitrates after treatment with N-acetylcysteine. Histological analysis showed vasodilatation in the lung, which was reversed by N-acetylcysteine. Micronuclei frequency and DNA damage in lung and liver were increased in the CBDL group. N-Acetylcysteine caused no genotoxic effect and did not influence the induction of micronucleus in bone marrow and DNA damage in lung and liver. The results suggest protective effects after treatment with N-acetylcysteine in cirrhotic rats with hepatopulmonary syndrome.
机译:这项研究的目的是使用大鼠胆总管结扎的实验模型评估N-乙酰半胱氨酸对肝硬化并发症肝肺综合征的潜在抗氧化作用。将雄性Wistar大鼠分为四个实验组:CBDL(动物接受胆总管结扎术); CBDL(动物接受胆总管结扎术); CBDL(实验动物)。假手术(动物接受模拟胆总管结扎术); Sham + N-乙酰半胱氨酸和CBDL + N-乙酰半胱氨酸。从手术后第14天开始,连续2周施用N-乙酰半胱氨酸(10mg / kg,腹膜内)。通过评估血清酶天冬氨酸转氨酶,丙氨酸转氨酶,碱性磷酸酶和动脉血气,研究了肝脏完整性的某些改变。通过硫代巴比妥酸反应性物质测定法进行的脂过氧化,超氧化物歧化酶活性和总硝酸盐作为氧化应激的参数进行了测量,对肺匀浆进行了测定。进行了骨髓中的微核测定以及肺,肝和血液中的彗星测定,以评估氧化应激的遗传毒性作用。结果表明,用N-乙酰半胱氨酸处理后,酶学参数和动脉血气有所改善,脂过氧化减少,总硝酸盐减少。组织学分析显示肺血管扩张,N-乙酰半胱氨酸逆转。 CBDL组肺和肝中的微核频率和DNA损伤增加。 N-乙酰半胱氨酸没有引起基因毒性作用,也没有影响骨髓中微核的诱导以及肺和肝中DNA的损伤。结果表明,N-乙酰半胱氨酸治疗肝硬化大鼠肝肺综合征后具有保护作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号